Common Stock, Shares, Issued of BIOADAPTIVES, INC. from 30 Jun 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
BIOADAPTIVES, INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Jun 2013 to 30 Sep 2025.
  • BIOADAPTIVES, INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 10,938,725, a 99% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 10,938,725 -1,220,790,249 -99% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 9,948,659 -1,221,780,315 -99% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 9,048,659 -1,145,721,982 -99% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 8,215,426 +2,243,698 +38% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,231,728,974 +455,254,951 +59% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 1,231,728,974 +655,254,951 +114% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 1,154,770,641 +769,843,359 +200% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 5,971,728 -246,583,037 -98% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 776,474,023 +643,538,159 +484% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 576,474,023 +499,016,540 +644% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 384,927,282 +326,576,703 +560% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 252,554,765 +201,734,985 +397% 31 Dec 2022 10-K 10 Apr 2024 2023 FY
Q3 2022 132,935,864 +97,135,819 +271% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 77,457,483 +44,425,058 +134% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 58,350,579 +25,318,154 +77% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 50,819,780 +29,227,838 +135% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 35,800,045 +16,214,274 +83% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 33,032,425 +14,171,146 +75% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 33,032,425 +14,456,046 +78% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 21,591,942 +3,015,563 +16% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 19,585,771 +756,662 +4% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 18,861,279 +765,110 +4.2% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 18,576,379 31 Mar 2020 10-Q/A 11 Jun 2020 2020 Q1
Q4 2019 18,576,379 +480,210 +2.7% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 18,829,109 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 18,096,169 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 18,096,169 31 Dec 2018 10-K/A 12 May 2020 2019 FY
Q3 2016 14,180,456 +1,444,020 +11% 30 Sep 2016 10-Q 18 Nov 2016 2016 Q3
Q2 2016 14,180,456 +1,444,020 +11% 30 Jun 2016 10-Q 18 Aug 2016 2016 Q2
Q1 2016 14,180,456 +1,444,020 +11% 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q4 2015 12,736,436 +100,000 +0.79% 31 Dec 2015 10-Q 18 Nov 2016 2016 Q3
Q3 2015 12,736,436 +100,000 +0.79% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 12,736,436 +100,000 +0.79% 30 Jun 2015 10-Q 21 Aug 2015 2015 Q2
Q1 2015 12,736,436 +650,000 +5.4% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 12,636,436 +594,769 +4.9% 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q3 2014 12,636,436 +2,636,436 +26% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 12,636,436 +2,636,436 +26% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 12,086,436 31 Mar 2014 10-Q 20 May 2014 2014 Q1
Q4 2013 12,041,667 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q3 2013 10,000,000 30 Sep 2013 10-Q 21 Oct 2013 2013 Q3
Q2 2013 10,000,000 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.